Nipro Corporation

8086

JP3673600007

Medical Equipment, Supplies & Distribution

Market Closed - Japan Exchange Other stock markets 02:00:00 2024-05-17 am EDT			5-day change	1st Jan Change
1,186 ^JPY	-1.29%		-5.91%	+7.18%

Apr. 12	Jefferies Adjusts Nipro’s Price Target to 1,400 Yen From 1,200 Yen, Keeps at Hold	MT
Jan. 11	Jefferies Adjusts Nipro's Price Target to 1,200 Yen From 1,000 Yen, Keeps at Hold	MT

Nipro Corporation authorizes a Buyback Plan.

July 02, 2018

The Board of Directors of Nipro Corporation has authorized a buyback plan on July 3, 2018.

Latest news about Nipro Corporation

Jefferies Adjusts Nipro’s Price Target to 1,400 Yen From 1,200 Yen, Keeps at Hold	Apr. 12	MT
Jefferies Adjusts Nipro's Price Target to 1,200 Yen From 1,000 Yen, Keeps at Hold	Jan. 11	MT
Jefferies Adjusts Nipro’s Price Target to 1,000 Yen From 1,100 Yen, Keeps at Hold	23-07-24	MT
Nipro Corporation Reports Earnings Results for the Full Year Ended March 31, 2023	23-05-11	CI
Nanotis Corporation announced that it has received funding from Nipro Corporation	22-07-04	CI
Shinsei Bank : Japan's Topix hits highest since 1990 on hopes of new govt, better earnings	21-09-10	RE
SBI : Japan shares rally on, Topix hits over 30-year high on earnings optimism	21-09-09	RE
Azgard Nine : Japan to consider sharing COVID-19 vaccines amid calls to help Taiwan	21-05-27	RE
AstraZeneca : Nipro to Manufacture AstraZeneca's COVID-19 Vaccine in Japan	21-05-26	MT
AstraZeneca : Nipro sign COVID-19 vaccine deal for supply in Japan	21-05-26	RE
Qol Holdings Co., Ltd. acquired remaining 49% stake in Nichihos Co.,Ltd. from Nipro Corporation.	21-04-08	CI
Nipro : Syringe shortage hampers Japan's COVID-19 vaccination roll out	21-02-15	RE
Nippon Electric Glass : Glass maker Schott predicts enough vials to go around for COVID-19 vaccines	21-01-20	RE
Exclusive: Bottlenecks? Glass vial makers prepare for COVID-19 vaccine	20-06-12	RE
JMI Syringes & Medical Devices Limited announced that it has received BDT 1.82151 billion in funding from Nipro Corporation	19-07-02	CI
Nagase & Co., Ltd. cancelled the acquisition of 5% stake in Yuki Gosei Kogyo Co., Ltd. from Nipro Corporation.	19-03-26	CI
JMI Syringes & Medical Devices Limited announced that it expects to receive BDT 1.82151 billion in funding from Nipro Corporation	19-01-02	CI
Tranche Update on Nipro Corporation's Equity Buyback Plan announced on July 3, 2018.	18-11-22	CI
Nipro Corporation's Equity Buyback announced on July 3, 2018 has expired with 3,520,600 shares for ¥4,999.92 million.	18-11-20	CI
Tranche Update on Nipro Corporation's Equity Buyback Plan announced on July 3, 2018.	18-10-01	CI
Samsung Electronics Plans To Sell Medical Unit To Nipro	18-09-20	CI
Nipro Corporation announces an Equity Buyback for 4,000,000 shares, representing 2.4% for ¥5,000 million.	18-07-03	CI
Nipro Corporation authorizes a Buyback Plan.	18-07-02	CI
Nipro Corporation Reports Consolidated and Non-Consolidated Earnings Results for the Year Ended March 31, 2018; Provides Consolidated Earnings Guidance for the Six Months Ending September 30, 2018 and Year Ending March 31, 2019	18-05-09	CI
Nagase & Co., Ltd. agreed to acquire 5% stake in Yuki Gosei Kogyo Co., Ltd. from Nipro Corporation for approximately ¥380 million.	18-03-26	CI

NIPRO CORPORATION is a manufacturer of medical devices, pharmaceuticals and instrument products. The Company has three segments. The Medical-Related segment involves in the sale of injections and infusions, artificial organs, high function and dialysis related medical equipment, and diabetes, generics and kits related medicine products in Japan, as well as the sales of medical devices for injection and infusion, artificial organs and diabetes in overseas markets. The Pharmaceutical-Related segment involves in the manufacture and sale of pharmaceuticals. The Pharma Packaging segment sells glass for vials and ampoules as medical glass in Japan, thermos glass for lighting and glass for lighting equipment.

Sector

Medical Equipment, Supplies & Distribution

Calendar

2024-08-05 - Q1 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Ratings for Nipro Corporation

Trading Rating

Investor Rating

ESG Refinitiv

C+

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

1,186 JPY

Average target price

1,475 JPY

Spread / Average Target

+24.32%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Medical Equipment, Supplies & Distribution

	1st Jan change	Capi.
NIPRO CORPORATION	+7.18%	1.26B
ABBOTT LABORATORIES	-5.24%	182B
MEDTRONIC PLC	+4.08%	114B
BECTON, DICKINSON AND COMPANY	-3.15%	68.38B
DEXCOM, INC.	+6.22%	52.46B
CENCORA, INC.	+8.06%	44.25B
HOYA CORPORATION	+7.52%	43.55B
METTLER-TOLEDO INTERNATIONAL, INC.	+25.07%	32.69B
TERUMO CORPORATION	+17.85%	26.73B
WEST PHARMACEUTICAL SERVICES, INC.	-0.65%	25.79B

Other Medical Equipment, Supplies & Distribution